• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

危险因素控制对周围动脉疾病结局和健康差异的影响。

Impact of risk factor control on peripheral artery disease outcomes and health disparities.

机构信息

Duke University School of Medicine, Durham, NC, USA.

Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.

出版信息

Vasc Med. 2022 Aug;27(4):323-332. doi: 10.1177/1358863X221084360. Epub 2022 Apr 7.

DOI:10.1177/1358863X221084360
PMID:35387516
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10908093/
Abstract

BACKGROUND

Peripheral artery disease (PAD) is associated with modifiable atherosclerotic risk factors like hypertension, diabetes, hyperlipidemia, and smoking. However, the effect of risk factor control on outcomes and disparities in achieving control is less well understood.

METHODS

All patients in an integrated, regional health system with PAD-related encounters, fee-for-service Medicare, and clinical risk factor control data were identified. Component risk factors were dichotomized into controlled and uncontrolled categories (control defined as low-density lipoprotein < 100 mg/dL, hemoglobin A1c < 7.0%, SBP < 140 mmHg, and current nonsmoker) and composite categories (none, 1, ⩾ 2 uncontrolled RFs) created. The primary outcome was major adverse vascular events (MAVE, a composite of all-cause mortality, myocardial infarction, stroke, and lower-extremity revascularization and amputation).

RESULTS

The cohort included 781 patients with PAD, average age 72.5 ± 9.8 years, of whom 30.1% were Black, and 19.1% were Medicaid dual-enrolled. In this cohort, 260 (33.3%) had no uncontrolled risk factors and 200 (25.6%) had two or more uncontrolled risk factors. Patients with the poorest risk factor control were more likely to be Black ( < 0.001), Medicaid dual-enrolled ( < 0.001), and have chronic limb-threatening ischemia ( = 0.009). Significant differences in MAVE by degree of risk factor control were observed at 30 days (none uncontrolled: 5.8%, 1 uncontrolled: 11.5%, ⩾ 2 uncontrolled: 13.6%; = 0.01) but not at 1 year ( = 0.08). risk factor control was not associated with outcomes at 1 year after adjustment for patient and PAD-specific characteristics.

CONCLUSIONS

risk factor control is poor among patients with PAD. Significant disparities in achieving optimal risk factor control represent a potential target for reducing inequities in outcomes.

摘要

背景

外周动脉疾病(PAD)与可改变的动脉粥样硬化风险因素有关,如高血压、糖尿病、血脂异常和吸烟。然而,风险因素控制对结果的影响以及在实现控制方面的差异尚不清楚。

方法

确定了一个综合的、区域性卫生系统中患有 PAD 相关疾病、按服务收费的医疗保险和临床风险因素控制数据的所有患者。将组成风险因素分为控制和未控制两类(控制定义为低密度脂蛋白<100mg/dL、糖化血红蛋白<7.0%、SBP<140mmHg 和当前非吸烟者),并创建了复合类别(无、1、≥2 个未控制的 RF)。主要结局是主要不良血管事件(MAVE,包括全因死亡率、心肌梗死、卒中和下肢血运重建和截肢的复合结局)。

结果

该队列包括 781 名 PAD 患者,平均年龄 72.5±9.8 岁,其中 30.1%为黑人,19.1%为医疗保险双重参保者。在该队列中,260 名(33.3%)患者没有未控制的风险因素,200 名(25.6%)患者有两个或更多未控制的风险因素。风险因素控制最差的患者更有可能是黑人(<0.001)、医疗保险双重参保者(<0.001)和患有慢性肢体威胁性缺血(=0.009)。在 30 天时,观察到风险因素控制程度与 MAVE 显著相关(无未控制因素:5.8%,1 个未控制因素:11.5%,≥2 个未控制因素:13.6%;=0.01),但在 1 年时无显著相关性(=0.08)。在调整患者和 PAD 特定特征后,风险因素控制与 1 年后的结局无关。

结论

PAD 患者的风险因素控制较差。在实现最佳风险因素控制方面存在显著差异,这代表了减少结果不平等的潜在目标。

相似文献

1
Impact of risk factor control on peripheral artery disease outcomes and health disparities.危险因素控制对周围动脉疾病结局和健康差异的影响。
Vasc Med. 2022 Aug;27(4):323-332. doi: 10.1177/1358863X221084360. Epub 2022 Apr 7.
2
The association of healthcare disparities and patient-specific factors on clinical outcomes in peripheral artery disease.医疗保健差距与患者个体因素对周围动脉疾病临床结局的影响。
Am Heart J. 2021 Sep;239:135-146. doi: 10.1016/j.ahj.2021.05.014. Epub 2021 May 27.
3
Regional variation in racial disparities among patients with peripheral artery disease.外周血管疾病患者中种族差异的地域差异。
J Vasc Surg. 2018 Aug;68(2):519-526. doi: 10.1016/j.jvs.2017.10.090. Epub 2018 Feb 16.
4
Racial disparities in outcomes of endovascular procedures for peripheral arterial disease: an evaluation of California hospitals, 2005-2009.外周动脉疾病血管内治疗结局的种族差异:对加利福尼亚州医院的评估,2005 - 2009年
Ann Vasc Surg. 2015 Jul;29(5):950-9. doi: 10.1016/j.avsg.2015.01.006. Epub 2015 Mar 7.
5
Epidemiology of lower extremity peripheral artery disease in veterans.下肢外周动脉疾病在退伍军人中的流行病学。
J Vasc Surg. 2018 Aug;68(2):527-535.e5. doi: 10.1016/j.jvs.2017.11.083. Epub 2018 Mar 24.
6
Chronic kidney disease and outcomes of lower extremity revascularization for peripheral artery disease.慢性肾脏病与外周动脉疾病下肢血运重建治疗结局。
Atherosclerosis. 2020 Mar;297:149-156. doi: 10.1016/j.atherosclerosis.2019.12.016. Epub 2019 Dec 24.
7
Clinician Specialty, Access to Care, and Outcomes Among Patients with Peripheral Artery Disease.临床科室专业、获得医疗服务的机会与外周动脉疾病患者的结局。
Am J Med. 2022 Feb;135(2):219-227. doi: 10.1016/j.amjmed.2021.08.025. Epub 2021 Oct 7.
8
Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study.2型糖尿病患者主要外周动脉疾病的表现及主要结局风险:ADVANCE-ON研究结果
Cardiovasc Diabetol. 2016 Sep 2;15(1):129. doi: 10.1186/s12933-016-0446-x.
9
Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk).依洛尤单抗降低低密度脂蛋白胆固醇水平及外周动脉疾病患者的结局:来自 FOURIER 试验(在高风险人群中用 PCSK9 抑制剂进行进一步心血管结局研究)的见解。
Circulation. 2018 Jan 23;137(4):338-350. doi: 10.1161/CIRCULATIONAHA.117.032235. Epub 2017 Nov 13.
10
High hemoglobin A associated with increased adverse limb events in peripheral arterial disease patients undergoing revascularization.血红蛋白 A 水平高与外周动脉疾病患者血运重建后不良肢体事件增加相关。
J Vasc Surg. 2018 Jan;67(1):217-228.e1. doi: 10.1016/j.jvs.2017.06.101. Epub 2017 Aug 31.

引用本文的文献

1
Risk factor management over two decades in hospitalised patients with chronic limb-threatening ischaemia with and without diabetes mellitus.20年来住院的伴有或不伴有糖尿病的慢性肢体威胁性缺血患者的危险因素管理。
Ther Adv Endocrinol Metab. 2025 Aug 22;16:20420188251362729. doi: 10.1177/20420188251362729. eCollection 2025.
2
Genetic association between immune-mediated inflammatory diseases and peripheral artery disease: a Mendelian randomization study.免疫介导的炎症性疾病与外周动脉疾病之间的遗传关联:一项孟德尔随机化研究。
Sci Rep. 2025 Jan 31;15(1):3891. doi: 10.1038/s41598-024-82987-3.
3
Quality of Life Outcomes Following Aortofemoral and Iliofemoral Bypass Surgery in Patients With Peripheral Arterial Disease: A Two-Year Follow-Up Study.外周动脉疾病患者行主-股动脉及髂-股动脉搭桥手术后的生活质量结果:一项为期两年的随访研究。
Cureus. 2024 Jun 3;16(6):e61598. doi: 10.7759/cureus.61598. eCollection 2024 Jun.
4
Racial and ethnic disparities in 3-year outcomes following infrainguinal bypass for chronic limb-threatening ischemia.慢性肢体严重缺血患者行腘动脉以下旁路手术后 3 年结局的种族和民族差异。
J Vasc Surg. 2022 Nov;76(5):1335-1346.e7. doi: 10.1016/j.jvs.2022.06.026. Epub 2022 Jun 26.

本文引用的文献

1
The association of healthcare disparities and patient-specific factors on clinical outcomes in peripheral artery disease.医疗保健差距与患者个体因素对周围动脉疾病临床结局的影响。
Am Heart J. 2021 Sep;239:135-146. doi: 10.1016/j.ahj.2021.05.014. Epub 2021 May 27.
2
The Groundwater of Racial and Ethnic Disparities Research: A Statement From .种族和族裔差异研究中的地下水:.的声明
Circ Cardiovasc Qual Outcomes. 2021 Feb;14(2):e007868. doi: 10.1161/CIRCOUTCOMES.121.007868. Epub 2021 Feb 11.
3
Model-Based Algorithms for Detecting Peripheral Artery Disease Using Administrative Data From an Electronic Health Record Data System: Algorithm Development Study.基于模型的算法利用电子健康记录数据系统中的管理数据检测外周动脉疾病:算法开发研究
JMIR Med Inform. 2020 Aug 19;8(8):e18542. doi: 10.2196/18542.
4
Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association.《心脏病与卒中统计-2020 更新:来自美国心脏协会的报告》。
Circulation. 2020 Mar 3;141(9):e139-e596. doi: 10.1161/CIR.0000000000000757. Epub 2020 Jan 29.
5
Risk factors and clinical outcomes in chronic coronary and peripheral artery disease: An analysis of the randomized, double-blind COMPASS trial.慢性冠状动脉和外周动脉疾病的风险因素和临床结局:对随机、双盲 COMPASS 试验的分析。
Eur J Prev Cardiol. 2020 Feb;27(3):296-307. doi: 10.1177/2047487319882154. Epub 2019 Oct 15.
6
Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis.2015 年全球、区域和国家外周动脉疾病的患病率和风险因素:更新的系统评价和分析。
Lancet Glob Health. 2019 Aug;7(8):e1020-e1030. doi: 10.1016/S2214-109X(19)30255-4.
7
Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia.全球血管指南:慢性肢体威胁性缺血的管理。
Eur J Vasc Endovasc Surg. 2019 Jul;58(1S):S1-S109.e33. doi: 10.1016/j.ejvs.2019.05.006. Epub 2019 Jun 8.
8
Disentangling Race, Poverty, and Place in Disparities in Physical Activity.解析体力活动差异中的种族、贫困和位置问题。
Int J Environ Res Public Health. 2019 Apr 3;16(7):1193. doi: 10.3390/ijerph16071193.
9
Medical and lifestyle management of peripheral arterial disease.外周动脉疾病的医学与生活方式管理
J Vasc Surg. 2018 Nov;68(5):1595-1606. doi: 10.1016/j.jvs.2018.07.027.
10
Association of Patient Perceptions of Cardiovascular Risk and Beliefs on Statin Drugs With Racial Differences in Statin Use: Insights From the Patient and Provider Assessment of Lipid Management Registry.患者对心血管风险的认知及对他汀类药物的信念与他汀类药物使用的种族差异的关系:来自患者和提供者评估血脂管理登记处的见解。
JAMA Cardiol. 2018 Aug 1;3(8):739-748. doi: 10.1001/jamacardio.2018.1511.